OptimizeRx to Participate at the 5th Annual ROTH London Conference on June 17-19, 2019
12 Juni 2019 - 2:31PM
OptimizeRx Corp. (NASDAQ: OPRX), a leading platform for
digital health messaging in the pharmaceutical industry, has been
invited to participate in the ROTH London Conference being held on
June 17-19, 2019 at the Dorchester Hotel in London, U.K.
OptimizeRx CEO William Febbo is scheduled to participate in
one-on-one meetings. This is the second year he has been invited to
participate. He will discuss a number of topics, including the
company’s record Q1 results and growing commercial team. He will
also discuss the company’s growing network that now reaches more
than half of the ambulatory patient market in the U.S., and provide
details around the company’s acquisition of CareSpeak that further
enhances the platform’s capabilities.
The ROTH London Conference will give investors extensive
interaction and one-on-one/small group meetings with management
teams from about 50 small/mid-cap companies in the technology,
cleantech and industrial sectors, and provide in-depth insights
into each of them.
The event is for institutional clients of ROTH and is by
invitation only. To schedule a one-on-one meeting with OptimizeRx,
please contact your ROTH sales representative at (800) 933-6830 or
conference@roth.com. For any questions about OptimizeRx, contact
Ron Both of CMA at (949) 432-7557 or submit your request here.
About OptimizeRx
OptimizeRx® (Nasdaq: OPRX), a digital health company, connects
pharmaceutical companies to patients and providers, offering
greater affordability, adherence and brand awareness at the
point-of-care. As the nation’s largest point-of-prescribe
promotional platform for the pharmaceutical
industry, OptimizeRx provides a direct channel
for pharma companies to communicate with healthcare
providers right within their workflow.
The cloud-based solution supports patient adherence to
medications with real-time access to financial assistance, prior
authorization, education and critical clinical
information. OptimizeRx provides more than half of the
ambulatory patient market with access to these benefits through
leading EHR platforms like Allscripts, Amazing Charts and
Quest, and directly via its mobile communications
platform.
For more information, follow the company on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
Statements This press release contains
forward-looking statements within the definition of Section 27A of
the Securities Act of 1933, as amended, and such as in section 21E
of the Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material
risks.
OptimizeRx Contact Doug
Baker, CFO Tel (248) 651-6568
x807 dbaker@optimizerx.com
Media Relations Contact Nicole
Brooks, Innsena Communications Tel (860) 800-2344 nicolebrooks@innsena.com
Investor Relations Contact Ron Both,
CMA Tel (949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024